Vir Biotechnology, Inc. VIR Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock shares issued?
- Vir Biotechnology, Inc. (VIR) reported common stock shares issued of 161.2M in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock shares issued changed year-over-year?
- Vir Biotechnology, Inc.'s common stock shares issued increased by 16.8% year-over-year, from 138.1M to 161.2M.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock shares issued?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s common stock shares issued has grown at a 1.5% compound annual growth rate (CAGR), from 133.2M to 139.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.